As shared marker of neurodegeneration, increased peripheral concentration of Nf-L has been detected in blood or cerebrospinal fluid of several neurological disorders, such as multiple sclerosis, amyotrophic lateral sclerosis, PD and atypical parkinsonisms, neurodegenerative dementias and traumatic brain injury (TBI) [9]. Here, NEFL is linked to Parkinson disease.